In order to ascertain whether insulin secretion is inhibited by insulin per se , the effect of exogenous rat insulin on basal and stimulatedrat C-peptide reactivity (CPR) release was studied in the isolated perfused rat pancreas . The pancreas was perfused with a medium containing 20 or 200 ng/ml of rat insulinfor a 20 min equilibration period and successively for a 25 to 30 min test period during which time glucose (300 mg/100 m/), tolbutamide (500 pg/m/), glucagon (500 ng/m/) or arginine (10mm) was added as a secretagogue.
Notwithstanding
the fact that many studies have been done on this question, in which a variety of techniques and different animal species were used, it is yet inconclusive whether insulin can inhibit insulin secretion or not. Grodsky (1968) , Malaisse et al. (1968) and Sando et al. (1970) denied the possibility of a feedback mechanism by which insulin secretion is inhibited by insulin itself. On the other hand there were an equivalent or greater number of contrasting data which pointed to the possible existence of the mechanism (Morgan et al., 1965; Logothetopoulos et al., 1965; Iversen and Miles, 1971; Ziegler et al., 1972; Ohgawara et al., 1973) . A couple of studies (Shima et al., 1977; Liljenquist et al., 1978) 
Materials and Methods
The pancreas was isolated from male Wistar rats weighing about 250 g after a 24 hr fast and was perfused by a modification of the method of Grodsky et al. (1963) . The perfusion fluid was Krebs Ringer bicarbonate buffer (pH 7.4) containing 0.1% BSA, 4.5% Dextran (m. wt. 70,000) and 60 mg/100 ml glucose. The concentration of glucose was increased to 100 mg/100 ml in the experiment in which glucagon was employed as a secretagogue.
The pancreas was first perfused for an equilibration period of 20 min with the basal perfusate in the presence of rat insulin (Novo Industries, Denmark) at a concentration of either 20 ng/ml or 200 ng/ml.
Then, glucose, tolbutamide, glucagon or arginine was added to obtain the concentration of 300 mg/100m/, 500 pg/m/, 500 ng/ ml or 10 mm in the influx medium. Perfusion was continued for a further period of 25 to 30 min. The effect of exogenous insulin on CPR release in the basal state was investigated during 30 min of perfusion with the basal perfusate following 20 min of equilibration.
The control experiment was carried out following the same procedure as described above, except that rat insulin was not added to the perfusion medium.
A constant flow rate of 2.2 min was produced with a piano-type peristaltic pump. A dequate oxygenation was achieved by lifting a thin film of perfusate on a rotating cylinder. Every 1-min efflux sample was collected into a tube containing Trasylol(R) (500 KIU/ml) and EDTA-2Na (1 mg/ml). The rat CPR concentration in the perfusate was measured by a modification of the doubleantibody radioimmunoassay method of Morgan and Lazarow (1963) , of which details have been described elsewhere (Yanaihara et al., 1979) . In brief, synthetic rat connecting peptide I and II were used for preparation of the standard and of rabbit anti C-peptide serum, respectively.
Tyrosylated rat connecting peptide I was iodinated for labelling C-peptide.
The antibody used in this study, R-901, binds predominantly to the C-terminal portion of the rat C-peptide molecule which is common to rat C-peptide I and peptides possible. Fig. 1 shows a typical standard curve.
The sensitivity of this assay system was 40 pg per tube or 0.2 ng/ml calculated as the 95% confidence limit of the blank. No CPR was detected in the rat insulin preparation at a concentration of 200 ng/ml, which was the highest concentration employed here. Statistical evaluation was done according to the Mann-Whitney U test. The same was true for IJCPR. And no significant difference was observed between the outcome of the test and the control experiment with respect to the peak value, the secretory pattern of CPR or IJCPR when glucagon or arginine was used as a secretagogue (Fig. 3 and Table 1 ).
Discussion
There has been controversy over whether there is a negative feedback mechanism for insulin which regulates insulin secretion. The controversy seems to have arisen primarily from a technical difficulty in measuring changes in endogenous insulin secretion in the presence of a large amount of exogenous insulin.
Subtle changes in insulin output could hardly be monitored by means of radioimmunoassay in the presence of an enormous amount of exogenous insulin. In an attempt to overcome this technical problem, investigators have turned to bonito insulin, which is dissimilar in structure to mammalian insulins and therefore does not disturb the assay of endogenous insulin. However, the structural dissimilarity of exogenous insulin raises the problem of whether that insulin really acts on the mammalian B cell in a similar way to endogenous insulin.
CPR is known to provide an accurate index of endogenous insulin secretion in the presence of exoge-
nous insulin or of anti-insulin antibody (Horwitz et al., 1976) . Since C-peptide and insulin are released from the pancreatic B-cell at an equimolar ratio, the former has been used in place of the latter as an index of the B-cell function. But, it is impossible to be sure that the ratio of release of one to the other may not become disproportionate under some special circumstances, though such a case has not yet been documented.
In evaluating the results, it may be necessary to take into account this possibility as well.
The results we obtained this time indicate that exogenous rat insulin does not suppress CPR secretion from the perfused rat pancreas in the basal state or in the glucose, tolbutamide, glucagon or arginine-stimulated state, but rather augments it. As described in the Materials and Methods section, the rat insulin preparation used in the present study was contaminated with no significant amount of CPR. Therefore, it is unlikely that the concentration of CPR in the perfusate in the test experiment higher than those in the control experiment were due to the rat CPR in the insulin preparation. This is supported by the fact that CPR response was not augmented in parallel with the concentration of rat insulin added to the medium. The present results suggest that possibly there exists a positive rather than negative feedback mechanism of insulin secretion. Except for the case of gonadotropin release (Hohlweg, 1934 ; Caligaris et al., 1971) , no such mechanism has been fully documented in the regulation of hormone secretion. Further studies are needed to clarify this. Apart from the question of positive feedback, there was no suppressive effect of exogenous insulin on CPR release in the perfused rat pancreas, to say the least. This is in essential agreement with the finding in our previous work on man (Shima et al., 1977) which demonstrated the inability of exogenous insulin to inhibit the secretory function of the B cell in the basal state. The conclusion we reached disagrees with that of Liljenquist et al. (1978) who used a similar method. In their study a much larger amount of insulin was administered for a longer period than in our previous in vivo study (Shima et al., 1977) . In the present experiment we utilized the same amount as in the experiment of Loreti et al. (1974) who used the largest amount of rat insulin ever employed in such experiments.
Therefore, it does not appear that our negative results can be ascribed to an inadequate concentration of insulin, although the exact insulin concentration in the fluid bathing the B cell is unknown. However, the difference in the length of time of insulin pretreatment is obvious. We pretreated the pancreas with exogenous insulin for 20 min before stimulation with various secretagogues, while Liljenquist et al. (1978) observed that a significant inhibition of basal and glucosestimulated insulin secretion was elicited following 60 min of pretreatment with exogenous insulin but not following 10 min of pretreatment. The prolonged infusion of exogenous insulin may stimulate release of some neurohumoral factors which inhibit insulin release, or otherwise may suppress insulin secretagogues such as glucagon and branched chain aminoacids.
If so, the inhibitory effect of insulin on insulin secretion is not a primary but a secondary one. The isolated perfused pancreas, however, offers several advantages over an in vivo system, whenever this feature of insulin secretion is investigated.
That the isolated perfused pancreas makes feasible the study of the effect of different substances on insulin secretion without the interaction of a secondary effect due to the potent counterregulation mechanisms present in vivo is one advantage.
The present study thus furnished additional evidence refuting the idea of a negative feedback mechanism in insulin secretion from the B cell.
